Click here to view and download the presentation
-
Upload
ringer21 -
Category
Technology
-
view
630 -
download
1
description
Transcript of Click here to view and download the presentation
www.kdigo.org
KDIGO Overview
Kidney Disease: Improving Global Outcomes
www.kdigo.org
• Mission
• Governance
• Clinical Practice Guidelines
• Controversies Conferences
• Guideline Coordination
• Guideline Implementation
• Website
KDIGO
Kidney Disease: Improving Global Outcomes
www.kdigo.org
KDIGO Mission
Kidney Disease: Improving Global Outcomes
www.kdigo.org
KDIGO
An independently incorporated nonprofit foundation, governed by an international board,
with the stated mission to:
‘Improve the care and outcomes of kidney disease patients worldwide through promoting coordination, collaboration, and integration of initiatives to develop and implement clinical
practice guidelines.’
Kidney Disease: Improving Global Outcomes
www.kdigo.org
KDIGO Governance
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Organizational Structure
Board Board
Board of Councelors(retired BOD members)
Board of Councelors(retired BOD members)
Management: National Kidney Foundation
Management: National Kidney Foundation
KDIGO Workgroups- CPG Workgroups- Liaison Task Force- Implementation Task Force
KDIGO Workgroups- CPG Workgroups- Liaison Task Force- Implementation Task Force
Evidence review:Evidence Review Team Tufts NEMC
Evidence review:Evidence Review Team Tufts NEMC
Executive Committee Executive Committee
Nominating committee
Nominating committee
Foundation under Belgium law
Kidney Disease: Improving Global Outcomes
www.kdigo.org
KDIGO Board of Directors
Omar I. Abboud, MD, SUDAN
Sharon Adler, MD, USA
Sharon P. Andreoli, MD, USA
Robert Atkins, MD, AUSTRALIA
Gavin Becker, MD, AUSTRALIA
Fred Brown, MBA, USA
Evelyn Butera, RN, USA
Daniel Cattran, MD, CANADA
Allan Collins, MD, USA
Ricardo Correa-Rotter, MD, MEXICO
Olivier Coustere, Tx Recipient, FRANCE
Adrian Covic, MD, ROMANIA
Jonathon Craig, MD, AUSTRALIA
Angel de Francisco, MD, SPAIN
Paul de Jong, MD, NETHERLANDS
Tilman Drüeke, MD, FRANCE
Garabed Eknoyan, MD, USA
Denis P. Fouque, MD, FRANCE
Mohammed Benghanem Gharbi, MD, MORROCO
Gordon Guyatt, MD, CANADA
Philip Halloran, MD, CANADA
Co-Chairs: Kai-Uwe Eckardt, MD GERMANY Bertram Kasiske, MD USA
Kidney Disease: Improving Global Outcomes
www.kdigo.org
KDIGO Board of DirectorsDavid Harris, MD, AUSTRALIA
Michel Jadoul, BELGIUM
Vivekanand Jha, MD, INDIA
Suhnggwon Kim, MD, KOREA
Martin Kuhlmann, MD, GERMANY
Adeera Levin, MD, CANADA
Nathan Levin, MD, USA
Phillip K.T. Li, MD, HONG KONG
Zhi-Hong Liu, MD, CHINA
Francesco Locatelli, MD, ITALY
Alison MacLeod, MD, UK
Pablo Massari, MD, ARGENTINA
Peter McCullough, MD, USA
Rafique Moosa, MD, SOUTH AFRICA
Miguel C. Riella, MD, BRAZIL
Bernardo Rodriguez-Iturbe, MD,
VENEZUELA
Robert Schrier, MD USA
Trent Tipple, MD,TX Recipient, USA
Yusuke Tsukamoto, MD, JAPAN
Raymond Vanholder, MD, BELGIUM
Giancarlo Viberti, MD, UK
Theodor Vogels, MSW, NETHERLANDS
David Wheeler, MD, UK
Carmine Zoccali, MD, ITALY
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Executive CommitteeCo-chairs: Kai-Uwe Eckardt Germany
Bertram Kasiske United States
Past co-chairs:Norbert Lameire BelgiumGarabed Eknoyan United States
Members: Adeera Levin CanadaNathan Levin United StatesFranceseco Locatelli Italy Alison MacLeod Scotland Miguel Riella Brazil Robert Schrier United States Yusuke Tsukamoto Japan Raymond Vanholder Belgium David Wheeler United Kingdom
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Clinical Practice Guidelines
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Guiding Principles for KDIGO Guideline Development
• Scientific and methodological rigor• Interdisciplinary approach• Independence of work groups• Transparency of the guideline development
process
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Quality of evidence
High A Strength of recom-mendation
1 Corresponds to “strong“ in GRADE Moderate B
Low C 2 Corresponds to “weak“ in GRADE
Very low De.g. (Grade 1C) or (Grade 2D) ……(8 options)
Plus option to include statements that are not graded
• 2 components of final grade: granularity and transparency
• Although quality of evidence influences strength of recommendation, no direct link • “Neutral“ alphanumeric code instead of terms that may be interpreted differently
Grading: The Quality of the Evidence and the Strength of the Recommendation
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Published Clinical Practice Guidelines
• Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in CKD– Published in Kidney International in April, 2008
• Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD– Published in Kidney International in July, 2009
• Care of Kidney Transplant Recipients– Published in the American Journal of Transplantation
in October, 2009; Executive Summary published inKidney International in December, 2009
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Guidelines in Development• Acute Kidney Injury
– Chairs: John Kellum & Norbert Lameire– Anticipated Publication: September, 2010
• Glomerulonephritis– Chairs: John Feehally & Dan Cattran– Anticipated Publication: December, 2010
• Hypertension– Chairs: Gavin Becker & David Wheeler– Anticipated Publication: July, 2011
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Guidelines in Development• Anemia in CKD
– Chairs: John McMurray and Patrick Parfrey– Initiate in March, 2010– Anticipated Publication in 2011
• CKD Classification and Treatment– Chairs: Adeera Levin and Paul Stevens– Initiate in Summer of 2010– Anticipated Publication in 2011/12
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Controversies Conferences
Kidney Disease: Improving Global Outcomes
www.kdigo.org
2010 KDIGO Controversies Conferences
• Drug Prescribing in Kidney Disease:
Initiative for Improved Dosing (May 2010)
Co-chairs: George Aronoff and Patrick Murray
• Cardiovascular Disease in CKD: What is it
and what can we do about it? (October 2010)Co-chairs: Eberhard Ritz and Charles Herzog
Kidney Disease: Improving Global Outcomes
www.kdigo.org
2011 Planned KDIGO Controversies Conferences
• Living Kidney Donor
(March 2011)
• Alternative Dialysis Techniques
(October 2011)
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Guideline Coordination
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Collaborating Guideline Groups
• Canadian Society of Nephrology (CSN) Guidelines• Caring for Australians with Renal Impairment (CARI)
Guidelines - ANZSN• United Kingdom Renal Association Guidelines• European Best Practice (EBPG) Guidelines –
ERA/EDTA• Kidney Disease Outcomes Quality Initiative (KDOQI)
Guidelines – NKF• ISN Guideline Committee
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Guideline Coordination
• Liaison Task Force
• Global Guideline Coordination Group
• ISN/KDIGO Collaboration Group
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Guideline Implementation
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Guideline Implementation
• Publish Guidelines in multiple languages on KDIGO website and in regional journals
• Commentaries from ISN, KDOQI, ERBP, UK-RA, CARI, and CSN
• Develop professional education tools based on KDIGO Guidelines
• KDIGO Implementation Task Force
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Implementation Task Force
The KDIGO Implementation Task Force is
charged with promoting awareness,
dissemination, adoption and clinical
integration of KDIGO Clinical Practice
Guidelines locally, around the world.
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Implementation Task Force
• Task Force divided into 6 regions
• Each Task Force Leader has designated Regional Representatives from the countries within their region
• There will be different approaches to guideline dissemination depending on the region and on the country
Type the Presentation Title here – Type the Presentation Subtitle here
Kidney Disease: Improving Global Outcomes
www.kdigo.org
KDIGO Implementation Task Force
LEADER REGION
Yusuke Tsukamoto (Chair) Asia Pacific
Michelle Josephson North America
Miguel Riella Latin America
Michel Jadoul Western Europe
Andrzej Więcek Eastern Europe
Mona Al Rukhaimi Middle East/Africa
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Implementation Task Force
Activities:• Facilitate and increase the number of
presentations on KDIGO guidelines at local, national, and regional meetings.
• Translate and submit guideline translations and executive summaries to regional journals for publication.
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Activities:• Promote integration and adoption of
guidelines into residency training programs.• Assist in developing commentaries / editorials
on KDIGO Guidelines for publication in regional journals.
• Communicate with regional healthcare administrators to promote adoption of practice guidelines.
Implementation Task Force
Kidney Disease: Improving Global Outcomes
www.kdigo.org
KDIGO Website
www.kdigo.org
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Website Resources
• KDIGO Guidelines:– All published guidelines available– Recommendations translated into multiple
languages– Slide presentations
• Reports from Controversies Conferences – Published position statements– Conference presentations
Kidney Disease: Improving Global Outcomes
www.kdigo.org
Website Resources
• Global Nephrology Guideline Database:– Guideline Overviews by Organization
– Guideline Summaries by Clinical Topic
www.kdigo.org
Thank you